Eloralintide 2883634-40-8 is an investigational, long-acting selective amylin receptor agonist developed for obesity treatment. It is designed to promote satiety, reduce food intake, and support body-weight reduction, with clinical research evaluating its safety, tolerability, and effectiveness in weight management.